ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard W. Bianco
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, J. N.
Right arrow Articles by Levy, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, J. N.
Right arrow Articles by Levy, R. J.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2005;79:897-904
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Prevention of Calcification of Bioprosthetic Heart Valve Cusp and Aortic Wall With Ethanol and Aluminum Chloride

Jocelyn N. Clark, PhDa, Matthew F. Ogle, BSb, Paul Ashworth, BSb, Richard W. Bianco, BSc, Robert J. Levy, MDa,*

a Division of Cardiology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
b St. Jude Medical, Inc, St. Paul, Minnesota
c Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota

Accepted for publication August 30, 2004.

* Address reprint requests to Dr Levy, Children's Hospital of Philadelphia, Abramson Research Center, Suite 702, 3615 Civic Center Boulevard, Philadelphia, PA 19104–4318; (E-mail: levyr{at}email.chop.edu).

BACKGROUND: Calcification is frequently associated with device failure of bioprostheses fabricated from either glutaraldehyde pretreated porcine aortic valves or bovine pericardium. It was hypothesized that differential pretreatment with ethanol-aluminum chloride will prove safe and efficacious for inhibiting the calcification of both the porcine aortic valve bioprosthetic cusp and the aortic wall.

METHODS: Glutaraldehyde-fixed porcine aortic valves were subjected to differential aluminum chloride (AlCl3) and ethanol pretreatment; aortic wall segments were treated exclusively with AlCl3 (0.1 moles/L) for 45 minutes, 6 hours, or 8 hours (groups 3A, B, and C, respectively), followed by valve cusp incubations in ethanol (80%, pH 7.4). Nontreated control bioprosthetic valves were either stent-mounted porcine aortic valve bioprostheses (Carpentier-Edwards, group 1) (Edwards, Santa Anna, CA) or St. Jude Toronto SPV valves (St. Jude Medical, St. Paul, MN) (group 2). Mitral valve replacements were carried out in juvenile sheep for 150 days.

RESULTS: Calcium in cusps from group 3A was 2.84 ± 0.62 mg calcium/g tissue versus control, 22.79 ± 8.46 mg calcium/g tissue, p = 0.04. Valves pretreated with AlCl3 for 45 minutes, 6 hours, and 8 hours had significantly lower levels of calcium in the aortic wall compared to controls (40.38 ± 5.66, 26.77 ± 4.02, and 28.94 ± 8.25 mg calcium/g tissue for groups 3A, 3B, and 3C, respectively, vs 95.47 ± 17.14 mg calcium/g tissue for group 1, p < 0.001, and 133.42 ± 3.96 mg calcium/g tissue for group 2, p < 0.001).

CONCLUSIONS: Differentially applied ethanol and aluminum chloride pretreatment significantly inhibited calcification of both the glutaraldehyde-fixed porcine aortic valve bioprosthetic cusp and the aortic wall.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.